Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclerosis: molecular imaging facilitates understanding of pathogenesis by Haider, Nezam et al.
ORIGINAL ARTICLE
Dual molecular imaging for targeting
metalloproteinase activity and apoptosis
in atherosclerosis: molecular imaging facilitates
understanding of pathogenesis
Nezam Haider, PhD,
a Dagmar Hartung, MD,
a Shinichiro Fujimoto, MD, PhD,
a
Artiom Petrov, PhD,
a Frank D. Kolodgie, PhD,
b Renu Virmani, MD,
b
Satoru Ohshima, MD, PhD,
a Han Liu, MS,
a Jun Zhou, MD,
a Ai Fujimoto, MD,
a
Atsuko Tahara, MD,
a Leo Hofstra, MD,
c Navneet Narula, MD,
d
Chris Reutelingsperger, PhD,
e and Jagat Narula, MD, PhD
a
Background. Macrophage apoptosis and MMP activity contribute to vulnerability of
atherosclerotic plaques to rupture. By employing molecular imaging techniques, we investi-
gated if apoptosis and MMP release are interlinked.
Methods. Atherosclerosis was produced in rabbits receiving high-cholesterol diet (HC),
who underwent dual radionuclide imaging with
99mTc-labeled matrix metalloproteinase
inhibitor (MPI) and
111In-labeled annexin A5 (AA5) using micro-SPECT/CT. %ID/g MPI and
AA5 uptake was measured, followed by histological characterization. Unmanipulated animals
were used as disease controls. Correlation between MPI and AA5 uptake was undertaken and
relationship conﬁrmed in culture study of activated THP-1 monocytes.
Results. MPI and AA5 uptake was best visualized in HC diet animals (n 5 6) and reduced
signiﬁcantly after ﬂuvastatin treatment (n 5 4) or diet withdrawal (n 5 3). %ID/g MPI
(.087 ± .018%) and AA5 (.03 ± .01%) uptake was higher in HC than control (n 5 6) animals
(.014 ± .004%, P < .0001; .0007 ± .0002%, P < .0001), and reduced substantially after diet or
statin intervention. There was a signiﬁcant correlation between MPI and AA5 uptake (r 5 .62,
P < .0001), both correlated with pathologically veriﬁed MMP-9 activity, macrophage content,
and TUNEL staining. In vitro studies demonstrated MMP-9 release in culture medium from
apoptotic THP-1 monocytes.
Conclusions. The present study suggests that apoptosis and MMP are interrelated in
atherosclerotic lesions and the targeting of more than one molecular candidate is feasible by
molecular imaging. (J Nucl Cardiol 2009;16:753–62.)
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INTRODUCTION
In two-thirds of patients presenting with acute cor-
onary syndromes, coronary thrombosis is associated
with rupture of the ﬁbrous cap of an atherosclerotic
plaque.
1 The triggers for the rupture include prevalence
of monocyte-macrophage inﬁltration and their apoptosis
as well as cytokine production including matrix
metalloproteinases (MMP). Almost one half of the
macrophages at the site of plaque rupture demonstrate
evidence of apoptosis with activation of caspase-1.
2 In
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753vitro experiments have conﬁrmed the role of caspase-1
in induction of apoptosis and the use of caspase-1
inhibitor (YVAD) substantially reduced the apoptosis of
macrophages in an experimental model of atheroscle-
rosis.
3 On the other hand, macrophage inﬁltration in the
plaque is associated with MMP expression and in turn to
degradation of extracellular matrix and cap rupture.
4
In addition to acting as a trigger to cap rupture,
macrophage apoptosis and MMP activity contribute to
plaque vulnerability. Apoptosis of macrophages in
necrotic core
5 leads to enlargement of the core size;
greater the necrotic core volume more prone is the plaque
to rupture.
6 On the other hand, the increase in MMP in
the necrotic core promotes expansive outward remodel-
ing of the plaque,
7 and renders the plaque susceptible to
rupture. These two processes, which are independently
critical for plaque rupture, are both related to macro-
phage inﬁltration and it is logical to presume that these
processes are interrelated. The apoptosis of cellular
components in an atherosclerotic plaque is no longer
considered an inert process. Fas-induced apoptosis of
smooth muscle cell (SMC) has been shown to produce
cytokines such as monocyte-chemoattractant protein 1
(MCP-1), CINC/IL-8, and other pro-inﬂammatory genes
resulting in an extensive macrophage inﬁltration.
8 Sim-
ilar to the SMC-related release of cytokines, it is possible
that apoptosis of macrophages may also be associated
with secretory activity.
To evaluate if apoptosis of macrophages is linked to
MMP and to determine the correlation of macrophage
apoptosis and MMP release in vivo, we performed
noninvasive imaging with
111In-annexin A5 (AA5; as a
marker of apoptosis) and
99mTc-labeled broad-spectrum
matrix metalloproteinase inhibitor (MPI; as a marker of
MMP activity) in rabbits with experimentally induced
atherosclerotic lesions. We also evaluated the interrela-
tion by inducing apoptosis of activated monocytes and
investigating whether the MMP activity was increased in
the culture medium.
METHODS
Noninvasive imaging was performed in atherosclerotic
rabbits for the detection of apoptosis process and MMP activity
by employing
111In-AA5 (which targets phosphatidyl serine
expression on the apoptotic cells) and
99mTc-MPI (which binds
to activated catalytic domain of MMP). The correlation of the
two processes was conﬁrmed in the in vitro experiments using
PMA-activated human monocytic leukemic cell line, THP-1.
The THP-1 cells were transfected with caspase-1 gene, and
MMP production was determined in the culture medium.
MMP-9 production and activity were measured by gel
zymography as reported previously by ELISA.
9 The effects of
caspase-1 inhibitor and endoplasmatic reticulum (ER) stress
inducers were also evaluated.
Atherosclerosis was produced experimentally in rabbits
by aortic deendothelialization and high-cholesterol (HC) diet.
To obtain a large range of macrophage inﬁltration, apoptosis,
and MMP production in the atherosclerotic lesions, the
hypercholesterolemic rabbits were subjected to dietary modi-
ﬁcation or treated with ﬂuvastatin. This protocol conforms to
the Guidelines for the Care and Use of Laboratory Animals by
the US National Institute of Health (NIH Publication No. 85-
23, revised 1996) and has been approved by the Institutional
Laboratory Animal Care and Use Committee at University of
California, Irvine.
In Vivo Experimental Design
The in vivo study was performed in 19 New Zealand
white (NZW) rabbits. Of the 19 rabbits, 13 rabbits were sub-
jected to balloon deendothelialization of their abdominal aorta
and were fed HC diet for 4 months to induce atherosclerotic
lesions. Of these, 3 atherosclerotic rabbits were returned to
normal chow in the last fourth month and 4 received ﬂuvastatin
(1 mg/kg p.o., once a day) in the last month. Dual imaging was
performed after simultaneous intravenous administration of
Tc-99m-labeled MPI (257.2 ± 3.7 MBq/6.95 ± 0.10 mCi) and
In-111-labeled annexin A5 (17.0 ± 6.29 MBq/0.46 ± 0.17
mCi). The remaining 6 rabbits were left unmanipulated for
4 months and fed normal chow. These animals were used for
dual imaging as disease controls.
Induction of atherosclerosis. Male NZW rab-
bits (2.5-3.5 kg) obtained from Western Oregon Breeding
Laboratories (Philomoth, OR) were started on 0.5% cholesterol
and 6% peanut oil diet. One week later, balloon deendotheli-
alization of the abdominal aorta was performed with a 4 F
Fogarty embolectomy catheter (12-040-4F; Edwards Lifesci-
ences LLC, Irvine, CA) as described previously.
10 For this
purpose, animals were anesthetized with a mixture of ketamine
and xylazine. The right femoral artery was surgically exposed,
an embolectomy catheter was introduced through the femoral
arteriotomy and advanced retrograde in the aorta up to the
level of the diaphragm. The catheter was inﬂated and endo-
thelial denudation of the abdominal aorta was performed by
pulling down the inﬂated catheter to the bifurcation of the
aorta. Three such passes were made. The femoral artery was
then ligated, and the incision site closed. The high-cholesterol,
high-fat diet was continued for 15 more weeks.
Imaging agents and radiolabeling. Two tar-
geting agents radiolabeled with two different isotopes were
employed for imaging. First, MPI (RP-805, kind gift of Lan-
theus Imaging Inc., North Billerica, MA) radiolabeled with
technetium-99m was used. The chemical structure of MPI has
been reported previously.
9,11 MPI binds speciﬁcally to the
activated catalytic domain of a broad range of MMP and not
other proteases,
12 and therefore has high enzyme inhibitory
proﬁle.
9 For radiolabeling of MPI, the contents of the vehicle
vial were dissolved in 0.5 mL of 0.9% sterile saline. The clear
solution was transferred to a vial containing 25-35 lg of MPI.
Subsequently the mixture was incubated for 10 minutes to
dissolve all particles and *3.33 GBq (90 mCi/mL) of
99mTc
pertechnetate was added. The reaction vial was heated at 100C
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the radioefﬁciency, which revealed product peak of[97%.
Second, AA5 binds to phosphatidylserin expressed on the
surface of apoptotic cells with a nanomolar afﬁnity. Normally,
AA5 has been radiolabeled with Tc-99m and employed suc-
cessfully for experimental and clinical imaging of apoptosis
noninvasively. For this study, we developed a novel imaging
strategy by labeling AA5 with indium-111. For radiolabeling
AA5, 55.5 MBq (1.5 mCi) of
111In was added to 30 lgo f
AA5-DTPA conjugate (kindly provided by PharmaTarget Inc,
Maastricht, Netherlands). After 30 minutes of incubation,
instant thin layer chromatography was performed.
In vivo and ex vivo imaging protocols.
Radionuclide imaging was performed immediately and 4 hours
after administration of radiotracers using a dual-head micro-
SPECT gamma camera combined with micro-CT (X-SPECT,
Gamma Medica, Inc., Northridge, CA). SPECT images of the
aorta were acquired in a 64 9 64 matrix, 32 stops at 20 seconds
(at 0 hour) or 120 seconds (at 4 hours) per stop ﬁrst at 140 keV
photopeak of
99mTc with 15% windows using a low-energy,
high-resolution parallel-hole collimator and second at 247 keV
photopeak of
111In with 15% windows using a medium energy
parallel-hole collimator. Immediately after SPECT imaging, a
micro-CT scan was acquired using an X-ray tube operating at
50 kVp and 0.6 mA. Images were captured for 2.5 seconds per
view for 256 views in 360 rotation. After transferring to
256 9 256 matrix, the micro-SPECT images and micro-CT
tomographic studies were fused. Animals were killed after
in vivo imaging, with an overdose of sodium pentobarbital
(120 mg/kg). Ex vivo gamma imaging of the excised aortas was
performed. The explanted aortas were imaged for 30 minutes.
After ex vivo imaging, the aortas were segmented at 1-cm
intervals, weighed, and gamma counted in an automatic well-
type gamma counter (Perkin Elmer Wallac Inc., Gaithersburg,
MD) for calculation of the percent total injected dose per gram
tissue (%ID/g) uptake. Aortas were then preserved for histo-
logic and immunohistochemical investigation.
Tissue samples of the main organs were used for
calculation of the %ID/g uptake to evaluate the biodistribution.
To correct for the radioactive decay and permit calculation of
the concentration of radioactivity as a fraction of the admin-
istered dose, aliquots of the injected dose were counted
simultaneously.
Histological and immunohistochemical
evaluation. One-half of every 1 cm aortic segment was
snap frozen and the other half was ﬁxed overnight with 4%
paraformaldehyde in PBS, pH 7.4 at 4C. The ﬁrst half of the
each specimen was subdivided into three equidistant sections,
dehydrated in a graded series of ethanol, and embedded in
parafﬁn for further processing in triplicate. Parafﬁn blocks
were cut in 4 lm thick sections, ﬂoated on a water bath con-
taining deionized water (43C), and mounted on vectabond
reagent-treated slides (Vectabond, SP-1800, Vector Labs,
Burlingame, CA). After deparafﬁnization by heating
(25 minutes at 56C) and dehydration using xylene and graded
series of ethanol, the tissue sections were stained with hema-
toxylin & eosin and Movat pentachrome stains. Histologic
specimens were analyzed using a classiﬁcation scheme based
on the recommendations of the American Heart Association
(AHA).
13
As described previously,
9,14 immunohistochemistry was
performed by standard staining procedures. Smooth muscle
cell (SMC) was identiﬁed using a primary antibody against
a-actin isotypes (MAB1420, 1:10,000, R&D Systems, Minne-
apolis, MI) and macrophages by RAM-11 (M 0633, 1:3,000,
DAKO, Carpinteria, CA). For MMP-9 staining in athero-
sclerotic lesions monoclonal MMP-9 (gelatinase-B, IM37,
1:15,000, Calbiochem) antibody was used. Color reaction was
developed by Novared substrate-chromogen system (SK-4800,
red color, Vector Lab) and diaminobenzidine kit (SK-4100,
DAB, brown color, Vector Lab, Burlingame, CA). The sec-
tions were counterstained with Gill’s hematoxylin. Sections
incubated in parallel without primary antibody or control IgG
were used as negative control. Immunostaining was observed
(Zeiss Axiovert-200 microscope, Carl Zeiss, Thornwood, NY)
and images captured (Zeiss Axiocam high-resolution digital
color camera, 1,300 9 1,030 pixels using Axiovision 3.1
software, Thornwood, NY). Digital images were analyzed
using Image-Pro Plus version 5.0 (Media Cybernetics,
Bethesda, MD). The percentage of immunopositive area
(immunopositive area/total intimal area 9 100) was
calculated.
In situ labeling of DNA fragmentation was performed
using terminal deoxyribonucleotide transferase (TdT)-medi-
ated nick-end labeling based on an in situ apoptosis detection
kit (TACS, Trevigen). Deparafﬁnized sections were treated
with 0.3% hydrogen peroxide for 10 minutes for inactivation
of endogenous peroxidase. The sections were rinsed and then
digested with 20 lg of proteinase K (EM Science). Exposed
DNA fragments were labeled with biotinylated nucleotides
(dNTPs) and TDT for 1 hour at 37C. The incorporation of
biotinylated nucleotides into DNA was detected with a strep-
tavidin-conjugated horseradish peroxidase. A positive reaction
was visualized with the chromogenic substance diam-
inobenzidine tinted with CoCl2, producing a black reaction
product. The sections were counterstained with methylgreen
(blue-green nuclei). The number of positive cells was counted
in the whole intima of each section.
In Vitro Experimental Design
Cell culture studies. The in vitro experiments
were performed with human monocytic leukemic cell line
(THP-1). Cells were grown in RPMI medium 1640 supple-
mented with 10% heat-inactivated fetal bovine serum,
100 units/mL penicillin, 100 lg/mL streptomycin, and 2 mM
L-glutamine at 37Ci n5 %C O 2.
Recombinant plasmid vectors. A full-length
cDNA of CASP1 was isolated from ICE-a pBluescript KS
plasmid
15 and was cloned into the Xba1-EcoR1 site of
eukaryotic expression vector pCDNA3 (Invitrogen corpora-
tion, Carlsbad, CA). Authenticity of the clone was conﬁrmed
by DNA sequencing. Empty control vector pcDNA3 and
cDNA of CASP1 cloned in reverse orientation into the
BamH1-EcoR1 site of pcDNA3 were used as negative
controls.
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growing THP-1 cells (1 9 10
7 cells) were washed and resus-
pended in 300 lL complete media containing 20 mM Hepes.
Cell suspension was mixed with 10 lg of pCDNA3-CASP1,
pCDNA3-CASP1-as, or pCDNA3 plasmid DNA and trans-
ferred to a cuvette (0.4-cm gap; BioRad Laboratories) and
electroporated (230 V, 960 lF, Gene Pulsar II, BioRad Lab-
oratories, Hercules, CA). Electroporated cells were diluted
with 10 mL of RPMI 1640 containing 10% fetal bovine serum,
100 IU/mL of penicillin, 100 lg/mL of streptomycin, and
0.6 mg/mL of glutamine, and grown at 37C for 48 hours.
MMP-2 and -9 productions were estimated in the culture
medium by gel zymography.
16 Release of MMP-9 and IL1-b in
the culture medium was also measured by activity assay and
ELISA. The effect of a caspase-1 inhibitor and an ER stress
inducer on MMP production was also evaluated.
Gel zymography. Culture supernatants were mixed
with SDS-sample buffer (50 mM Tris-HCl pH 6.8, 10% glyc-
erol, 1% SDS, 0.01% bromophenol blue) in the absence of
reducing agent and electrophoresed in a 7.5% SDS-polyacryl-
amide gel containing 0.1% (w/v) gelatin. The gel was incubated
at room temperature for 1 hour in 2.5% TritonX 100 and sub-
sequently at 37C overnight in a buffer containing [10 mM
CaCl2, 150 mM NaCl, and 50 mM Tris (pH 7.5) 0.02% NaN3].
The gel was then stained for protein with 0.25% Coomassie.
Gelatinolyticactivitywasdetectedasaclearzoneinadarkﬁeld.
Matrix metalloproteinase activity assays.
For MMP assay, MMP-9 Biotrak Activity Assay System and
Interleukin-1 b Biotrak ELISA system (GE Healthcare
Bio-Sciences, Piscataway, NJ) were used according to
manufacturer’s protocol. THP-1 culture medium was collected
for MMP assay after 48 hours of transfection or 24-48 hours
treatment with different inducers.
Reagents. Cell-permeable caspase-1 inhibitor YVAD-
CHO, caspase-3 inhibitor DEVD-CHO, and broad-spectrum
caspase inhibitor Z-VAD-FMK, (BIOMOL International,
Plymouth Meeting, PA) were used. 7-ketocholesterol, choles-
terol-5b, ionomycin, and thapsigargin were purchased from
Sigma Chemical Co. (St. Louis, MO).
Statistical Analyses
All results are presented as the mean ± SD. To determine
the statistical signiﬁcance of differences between groups one-
way ANOVA was used followed by post hoc analysis using
Fisher’s PLSD. P value of \.05 was considered statistically
signiﬁcant. Blood radioactivity of MPI and AA5 was presented
as the mean (±SD) percent ID/g of tissue and was plotted as a
function of time after injection. The clearance curves were
ﬁtted to biexponential functions by nonlinear least squares.
RESULTS
Noninvasive Detection of MMP Expression
and Apoptosis in Atherosclerotic Lesions
In vivo dual radionuclide micro-SPECT/CT study
was performed immediately and 4 hours after simulta-
neousintravenousadministrationofTc-MPIandIn-AA5.
Figure 1. Noninvasive radionuclide imaging of Tc-MPI and In-AA5 in atherosclerosis. Micro-
SPECT (top), and micro-SPECT-CT fusion images (bottom) of atherosclerotic rabbit on
uninterrupted HC diet using Tc-MPI (A) and In-AA5 (B). The left sets in A and B display
images immediately (0 hour) after radiotracer administration, which reveal blood pool activity in
the aorta (arrows) in front of vertebral column. The right sets in A and B show target localization
4 h after radiotracer administration. The radiotracer uptake in the atherosclerotic lesions of the
abdominal aorta is observed (arrows).
756 Haider et al Journal of Nuclear Cardiology
Dual molecular imaging for targeting metalloproteinase activity and apoptosis September/October 2009The SPECT images obtained at the time of radiotracer
injection demonstrated aortic blood pool activity in ani-
mals of all study groups. The lesion uptake of both
radiotracers was visualized best at 4 hours after tracer
administration in the abdominal aorta of animals on
uninterrupted HC diet (Figure 1). MPI and AA5 uptake
was substantially reduced after diet withdrawal and
treatment with ﬂuvastatin. No uptake of the radiotracers
was seen in unmanipulated disease control animals.
The uptake of both radiotracers was conﬁrmed in
the ex vivo gamma images of the excised aortas, which
conﬁrmed the in vivo uptake distribution (Figure 2A).
Contrary to the negative control, signiﬁcant radiotracer
accumulation was seen in the abdominal aorta of the
atherosclerotic animals placed on an uninterrupted HC
diet. MPI and AA5 uptake was clearly reduced in the
diet-withdrawal and statin groups, and no uptake was
seen in unmanipulated disease control animals.
Quantitative MPI and AA5 Uptake
The percent ID/g uptake of MPI in the atheroscle-
rotic lesions of the animals on uninterrupted high-
cholesterol diet (0.087 ± 0.018%) was signiﬁcantly
higher than the uptake in the abdominal aorta of disease
control animals (0.014 ± 0.004%; P\.0001). The
quantitative MPI uptake in diet-withdrawal group
(0.047 ± 0.005%; P\.0005) and ﬂuvastatin-treated
animals (0.053 ± 0.013%; P\.01) was signiﬁcantly
lower compared to uninterrupted HC diet group
(0.087 ± 0.018%) (Figure 2B). Similarly, the percent
ID/g AA5 uptake in the atherosclerotic lesions of ani-
mals with uninterrupted HC diet (0.03 ± 0.01%) was
signiﬁcantly higher than the uptake in disease control
rabbits (0.0007 ± 0.0002%; P\.0001). The quantita-
tive uptake of AA5 in diet-withdrawal group (0.018 ±
0.004%; P\.05) and ﬂuvastatin-treated groups (0.018 ±
0.01%; P\.05) was signiﬁcantly lower compared to
uninterrupted HC diet group (Figure 2B).
There was a strong correlation between MPI and
AA5 uptake in the atherosclerotic lesions (r = 0.62,
P\.0001) (Figure 2C).
Histopathologic Characterization
of Atherosclerotic Lesions
TheatheroscleroticlesionsintheHCdietgroupwere
extensive and predominantly comprised AHA type IV
lesions, showing high macrophage content, signiﬁcant
macrophage apoptosis, low SMC prevalence, and
upregulation of MMP-9 (Figure 3A). The macrophage
content, the incidence of apoptosis, and the MMP
expression were markedly reduced in the intervention
groups. There was a signiﬁcant relationship between
%ID/g MPI or AA5 uptake and expression of MMP-9
(r = 0.786,P\.0001;r = 0.562P\.05,respectively).
The quantitative uptake of both MPI and AA5 was
directly related to macrophage content (r = 0.781,
P\.0001; r = 0.604, P\.01, respectively) and
TUNEL staining (r = 0.697, P\.001; r = 0.652,
P\.005, respectively) (Figure 3B).
Figure 2. Radiotracer uptake in the aorta by ex vivo imaging
and quantitative estimates of Tc-MPI and In-AA5%ID/g
uptake. A Ex vivo images of explanted aortas of the different
study groups (control; HC diet; diet withdrawal; ﬂuvastatin)
are displayed. Each column shows two images of the same
aorta; In-AA5 (right) and Tc-MPI (left). Intense uptake of Tc-
MPI and In-AA5 within the abdominal aortas of rabbits on
uninterrupted HC diet is observed. The uptake of both
radiotracers is signiﬁcantly reduced in ﬂuvastatin-treated and
diet-withdrawal rabbits. No uptake of both radiotracers is
observed in the control animals. B Quantitative %ID/g Tc-MPI
uptake (black bar) and In-AA5 uptake (open bar) of the
different study groups is shown. Uptake of both radiotracers is
signiﬁcantly reduced in statin-treated and diet-withdrawal
animals compared to the animals on uninterrupted HC diet.
C A signiﬁcant correlation of Tc-MPI and In-AA5 uptake in
different groups is observed.
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Caspase-1 expression in THP-1 cells induced a
marked increase in MMP-9 production and extracellular
release into the culture medium as assessed by gel zy-
mography (Figure 4A). Cells transfected with empty
vector or CASP1 cloned in reverse orientation had no
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Figure 3. Histopathological and immunohistopathological characterization of atherosclerotic
lesions in HC diet group compared to control animals. Representative microphotographs from
HC diet (bottom) and control animals (top) are shown. A Movat pentachrome, RAM-11
(macrophages), and a-actin (smooth muscle cells), B RAM-11 terminal deoxyribonucleotide
transferase-mediated nick-end labeling (TUNEL) staining, matrix metalloproteinase MMP-9
immunostaining are shown. Atherosclerotic lesion in the HC group predominantly belongs to AHA
type IV lesions and show high macrophage, low SMC, high MMP-9 content. The control group has
no atherosclerotic lesions, no apoptosis, and no MMP-9 expression. C Correlation between
quantitative Tc-MPI and In-AA5 uptake in %ID/g and pathologically veriﬁed positive area of
RAM-11, MMP-9, and TUNEL staining. A signiﬁcant correlation between the quantitative
radiotracers uptake and RAM-11, MMP-9, and TUNEL staining are observed.
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increase in MMP-9 activity in CASP1-transfected cells
in comparison to the negative controls in bioactivity
assay (Figure 4C). There was also a parallel increase in
IL1-b level in this group (Figure 4D). CASP1 over-
expression, however, exerted no effect on MMP-2 level,
which remained unchanged in all groups (Figure 4A
and B). CASP1-mediated increase in MMP-9 was
inhibited by cell-permeable broad-spectrum caspase
inhibitor, Z-VAD-FMK, and a CASP1 speciﬁc inhibitor,
YVAD-CHO (Figure 5A). YVAD-CHO at 1 lM con-
centration reduced the level of MMP-9 release and its
activity by more than 50% (Figure 5B and C). On the
other hand, a caspase-3 inhibitor, DEVD-CHO, had no
signiﬁcant effect on MMP-9 level (Figure 5A), which
indicated that CASP1 was primarily responsible for the
increase in MMP-9.
We also evaluated the role of oxysterol, cholesterol-
5b, and 7-ketocholesterol, present in atherosclerotic
lesions and reported to induce SMC death and plaque
destabilization, on MMP-9. THP-1 cells treated with
40 lg/mL of 7-ketocholesterol and 30 lM of choles-
terol-5b induced the expression and release of MMP-9
(Figure 5D). Apoptosis induced by oxLDL is mediated
through Ca
2? inﬂux and Ca
2? deregulation. THP-1 cells
treated with 1 lM thapsigargin, an inhibitor of sarco-
plasmic reticulum Ca
2? ATPase (SERCA) which raises
cytosolic calcium concentration also induced higher
MMP-9 release (Figure 5D). But ionomycin, a potent
and selective Ca
2? ionophore, which acts primarily at
the level of the internal Ca
2? stores and enhances Ca
2?
inﬂux, had no effect on MMP-9 expression level
(Figure 5D). Lipopolysaccharide (LPS) treatment
induced higher MMP-9 expression and extracellular
release into the medium, but exactly similar to CASP1
overexpression had no effect on MMP-2 level (Fig-
ure 5E). MMP-2 and -9 levels remained unchanged in
interferon-gamma (IFN-c)-treated THP-1 cells.
DISCUSSION
The direct relationship between macrophage apop-
tosis and MMP release was observed in imaging
experiments, which was maintained over the broad
range of prevalence of apoptosis and MMP production.
Both, the MMP production and apoptosis were sub-
stantially reduced in diet-withdrawal and statin
treatment groups. MPI and AA5 uptake correlated with
pathologically veriﬁed apoptosis and macrophage, and
MMP-9 positive areas in the atherosclerotic lesions.
This relationship was conﬁrmed in culture experiments.
Both, in vitro and in vivo experiments demonstrated that
macrophage apoptosis and MMP production may be
intimately related and highlight the importance of
inﬂammation in plaque vulnerability.
Macrophage Apoptosis and MMP Release
Although not evaluated in atherosclerosis, neurons
under cellular stress undergo apoptosis and release
MMP-3.
17 The MMP-3 upregulation occurs upstream of
caspase-3 (CASP3) activation but downstream of c-Jun
N-terminal protein kinase (JNK) in the apoptosis sig-
naling cascade. C-Jun, phosphorylated by JNK, acts as a
transcription factor for MMP-3 gene. However, our
experiments suggest that apoptosis may be upstream to
MMP-9 release. Differentiated versus undifferentiated
Figure 4. Expression of MMP-9 in CASP1 transfected THP-1
Cells. A Zymogram: caspase-1 transduction of human mono-
cyte THP-1 cells strongly induced MMP-9 expression as
analyzed in the culture medium. Cells transfected with empty
vector or vector containing CASP1 cloned in reverse orienta-
tion [CASP1(as)] did not induce MMP-9 expression. CASP1
expression did not result in MMP-2 expression. B Total cell
lysate also reveals MMP-9 in CASP1 transfected THP-1 cells.
C Substantially increased level of MMP-9 enzymatic activity
is seen in CASP1 expressing THP-1 cells, as is the increased
level of IL1-b in CASP1 expressing THP-1 cells (D).
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MMP-9 may explain some of the differences. Our study
suggests that CASP1, besides its pro-inﬂammatory
actions, has pro-apoptotic potential.
3 In patients dying of
acute coronary events, extensive apoptosis of macro-
phages, CASP1 activation, and increased MMP-9
activity have been demonstrated at the site of plaque
rupture.
2 We have also observed CASP1-mediated
apoptosis of macrophages in advanced experimental
atherosclerosis in a rabbit model.
3 On the other hand, a
possible role of MMP in inducing apoptosis in athero-
sclerosis is unclear. Besides extracellular matrix
proteins, MMP are known to degrade integrins,
18 and
may promote apoptosis of SMC by cell-surface N-cad-
herin shedding. Also by liberating nonmatrix substrates
such as growth factors from attachment to matrix com-
ponents or cell surface, MMP can inﬂuence apoptosis.
19
MMP can modulate apoptotic signaling by release of
FasL
20 and TNF-a
21 from cell surface.
Active MMP-3 has also been found in the nucleus
of several cultured cell types and may be associated with
an increased rate of apoptosis.
22 Pro-MMP-2 has been
found in the nucleus of cardiomyocytes; activated
nuclear MMP-2 results in DNA repair enzyme poly-
ADP ribose-polymerase (PARP) fragmentation and may
increase genetic instability to trigger apoptosis.
23 In
adrenergic receptor-stimulated rat cardiac myocytes,
MMP-2 impairs b1 integrin-mediated survival signals,
such as activation of focal adhesion kinase (FAK), and
activates the JNK-dependent mitochondrial death path-
way leading to apoptosis.
24
Role of Imaging MMP and Apoptosis
Radiolabeled annexin A5 has been successfully
employed for the noninvasive detection of macrophage
apoptosis in atherosclerotic plaque
10,25 and treatment-
related changes in apoptosis.
3 Similarly, imaging of
MMP activity and treatment-related changes in MMP
content within the plaque with a radiolabeled MPI has
also been successfully demonstrated previously.
9 Lipid
lowering by dietary modiﬁcation or HMG-CoA reduc-
tase inhibitors, which are associated with an abrogation
of apoptosis and a reduction of MMP in plaque are
known to stabilize atherosclerotic plaques.
Although not undertaken, it is frequently proposed
that multiple tracers may be combined for improving
diagnostic accuracy of an imaging procedure for iden-
tiﬁcation of a disease process. Such suggestion is often
based on the observed incremental value of combining
circulating biomarkers for risk prediction. The direct
relationship and similar response to therapeutic
Figure 5. Effect of caspase inhibitors on the expression of MMP-9 in CASP1-transfected THP-1
cells. A Zymogram: Z-VAD-FMK, a cell-permeable broad-spectrum caspase inhibitor and YVAD-
CHO, a CASP1 speciﬁc inhibitor, show marked inhibition of MMP-9 release from THP-1 cells.
DEVD-CHO, a caspase-3 speciﬁc inhibitor, had no effect on MMP-9 expression and release. B, C.
MMP-9 enzymatic activity in CASP1 expressing THP-1 cell lysate is signiﬁcantly reduced by a
CASP1 speciﬁc inhibitor YVAD-CHO. D Effect of ER stress on the expression of MMP-9 in THP-
1 cells, as shown by oxysterols, 7-ketocholesterol, and cholesterol-5b induce MMP-9 release from
THP-1 cells. SERCA inhibitor thapsigargin also induces MMP-9 expression while it remains
unchanged in ionophore ionomycin-treated cells. E Cells treated with LPS release MMP-9 into the
medium. IFNc has no effect on MMP-9 expression. MMP-2 level remains unchanged in both
groups.
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may not be as advisable to combine two interrelated
components of the same pathologic cascade. The
incremental value of the diagnostic procedure may be
based on combination of morphological and functional
imaging or the molecular targeting of the components of
different cascades. The example of the latter approach
may include functional imaging for identiﬁcation of an
increase in vasa vasorum or neovascularization with
either apoptosis or MMP imaging. Nonetheless, the
present study suggests that molecular imaging allows
better understanding of a pathogenetic process of disease
manifestation. On the other hand, knowledge of a
pathological mechanism may allow for better develop-
ment of novel imaging techniques. This uncovers the
strength of molecular imaging and may lead to better
management and preventive strategies (Figure 6).
26
CONCLUSIONS
The present study demonstrates the feasibility of
molecular imaging of more than a single target by using
different tracers. If the candidate targets are interrelated,
dual imaging may not offer sufﬁcient incremental value.
Nonetheless, molecular imaging helps understand the
pathogenesis of a disease better and vice versa; better
understanding of a disease process may allow develop-
ment of improved diagnostic strategies.
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